BioAxone BioSciences Expands Patent for Treatment of Cerebral Cavernous Malformations and Cerebral Aneurysms with Rho Kinase Inhibitors

The notice refers to a critical patent application (US 15/988,736) covering the oral drug candidate in development, BA-1049.